• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖、2型糖尿病与女性乳腺癌之间的复杂关系:一项针对335名女性的回顾性研究。

The intricate relationship between obesity, type 2 diabetes and female breast cancer: A retrospective study of 335 women.

作者信息

Milani Ilaria, Gaita Chiara, Guarisco Gloria, Chinucci Marianna, Parisella Roberta, Piroli Silvia, Bruno Eleonora, Martellucci Annunziata, De Falco Elena, Ricci Fabio, Calogero Antonella, Leonetti Frida, Capoccia Danila

机构信息

Department of Medico-surgical Sciences and Biotechnologies University of Rome La Sapienza Faculty of Pharmacy and Medicine Latina Lazio Italy.

Breast Unit Hospital Santa Maria Goretti Latina Lazio Italy.

出版信息

Obes Sci Pract. 2024 Aug 9;10(4):e786. doi: 10.1002/osp4.786. eCollection 2024 Aug.

DOI:10.1002/osp4.786
PMID:39130194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11310762/
Abstract

BACKGROUND

Type 2 diabetes (T2D) is a risk factor for female breast cancer (FBC). Obesity has also been associated with FBC, also depending on menopausal status. This study aimed to evaluate the impact of obesity and T2D on the development, aggressiveness, and invasiveness of FBC.

METHODS

Demographic, clinical, and histopathological data from 335 women with FBC were collected, and analyzed according to weight category (102 normal weight, 117 overweight, and 116 living with obesity) and the presence/absence of T2D.

RESULTS

Age at oncologic diagnosis was not statistically significantly different for body weight; women with overweight or obesity were more likely to have an oncologic diagnosis after menopause than normal weight ( < 0.001). The presence of overweight/obesity and T2D seemed to be associated with a higher incidence of metastasis, recurrence, and triple-negative breast cancer (TNBC) subtype ( < 0.001). Excess body weight was also associated with high histologic grade (G3) ( < 0.005).

CONCLUSIONS

These results confirm excess body weight and T2D as unfavorable prognostic factors in terms of the presence of the TNBC subtype, tumor metastasis, recurrence, and aggressiveness (G3 and Ki-67 > 20%). This study highlights the importance of prevention in all women, with early screening, and adequate nutritional programs.

摘要

背景

2型糖尿病(T2D)是女性乳腺癌(FBC)的一个危险因素。肥胖也与FBC相关,这也取决于绝经状态。本研究旨在评估肥胖和T2D对FBC发生、侵袭性和浸润性的影响。

方法

收集了335例FBC女性的人口统计学、临床和组织病理学数据,并根据体重类别(102例体重正常、117例超重和116例肥胖)以及是否存在T2D进行分析。

结果

肿瘤诊断时的年龄在体重方面无统计学显著差异;超重或肥胖的女性在绝经后被诊断出患癌的可能性高于体重正常者(<0.001)。超重/肥胖和T2D的存在似乎与转移、复发和三阴性乳腺癌(TNBC)亚型的发生率较高相关(<0.001)。超重还与高组织学分级(G3)相关(<0.005)。

结论

这些结果证实,就TNBC亚型的存在、肿瘤转移、复发和侵袭性(G3和Ki-67>20%)而言,超重和T2D是不良预后因素。本研究强调了对所有女性进行预防的重要性,包括早期筛查和适当的营养计划。

相似文献

1
The intricate relationship between obesity, type 2 diabetes and female breast cancer: A retrospective study of 335 women.肥胖、2型糖尿病与女性乳腺癌之间的复杂关系:一项针对335名女性的回顾性研究。
Obes Sci Pract. 2024 Aug 9;10(4):e786. doi: 10.1002/osp4.786. eCollection 2024 Aug.
2
Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience.土耳其患者群体中三阴性乳腺癌患者的临床病理和人口统计学评估:单中心经验
Asian Pac J Cancer Prev. 2013;14(10):6013-7. doi: 10.7314/apjcp.2013.14.10.6013.
3
Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women.超重作为中国女性三阴性乳腺癌的一个预后因素。
PLoS One. 2015 Jun 24;10(6):e0129741. doi: 10.1371/journal.pone.0129741. eCollection 2015.
4
Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.中年 2 型糖尿病和肥胖与雷克雅未克队列乳腺癌风险的关系。
Cancer Causes Control. 2019 Oct;30(10):1057-1065. doi: 10.1007/s10552-019-01213-y. Epub 2019 Aug 10.
5
Breast cancer subtype distribution is different in normal weight, overweight, and obese women.正常体重、超重和肥胖女性的乳腺癌亚型分布有所不同。
Breast Cancer Res Treat. 2017 Jun;163(2):375-381. doi: 10.1007/s10549-017-4192-x. Epub 2017 Mar 14.
6
Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer.新辅助化疗期间体重变化对三阴性乳腺癌病理反应的影响。
Cancer Med. 2015 Apr;4(4):500-6. doi: 10.1002/cam4.388. Epub 2015 Jan 30.
7
Body Weight, Central Adiposity, and Fasting Hyperglycemia Are Associated with Tumor Characteristics in a Brazilian Cohort of Women with Breast Cancer.在巴西乳腺癌女性队列中,体重、中心性肥胖和空腹高血糖与肿瘤特征相关。
Nutrients. 2022 Nov 21;14(22):4926. doi: 10.3390/nu14224926.
8
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.超重、肥胖与绝经后浸润性乳腺癌风险:妇女健康倡议随机临床试验的二次分析。
JAMA Oncol. 2015 Aug;1(5):611-21. doi: 10.1001/jamaoncol.2015.1546.
9
The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.肥胖对绝经前女性乳腺癌分子亚型的预后影响。
J BUON. 2013 Apr-Jun;18(2):335-41.
10
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.除腋窝淋巴结转移外,体重指数和绝经状态是新辅助化疗治疗三阴性乳腺癌的预后决定因素。
PLoS One. 2015 Dec 18;10(12):e0144359. doi: 10.1371/journal.pone.0144359. eCollection 2015.

引用本文的文献

1
PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation.糖尿病引起的代谢和免疫激活改变的正电子发射断层显像(PET)成像
Mol Imaging Biol. 2025 Aug 12. doi: 10.1007/s11307-025-02027-y.

本文引用的文献

1
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism.不良代谢健康对侵袭性乳腺癌的影响:脂肪组织和肿瘤代谢。
Front Endocrinol (Lausanne). 2023 Sep 20;14:1217875. doi: 10.3389/fendo.2023.1217875. eCollection 2023.
2
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.超重与绝经后乳腺癌:新出现的分子机制及展望
Semin Cancer Biol. 2023 Nov;96:26-35. doi: 10.1016/j.semcancer.2023.09.003. Epub 2023 Sep 20.
3
The Role of Obesity in Breast Cancer Pathogenesis.肥胖在乳腺癌发病机制中的作用。
Cells. 2023 Aug 14;12(16):2061. doi: 10.3390/cells12162061.
4
The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk.肥胖与乳腺癌风险之间的分子和遗传相互作用。
Medicina (Kaunas). 2023 Jul 21;59(7):1338. doi: 10.3390/medicina59071338.
5
The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis.考虑到月经状态和地理差异,肥胖与女性乳腺癌风险之间的关系:系统评价和荟萃分析。
BMC Womens Health. 2023 Jul 26;23(1):392. doi: 10.1186/s12905-023-02543-5.
6
Obesity and menopause.肥胖与绝经。
Best Pract Res Clin Obstet Gynaecol. 2023 Jun;88:102348. doi: 10.1016/j.bpobgyn.2023.102348. Epub 2023 May 6.
7
Beyond BMI.超越 BMI(身体质量指数)。
Nutrients. 2023 May 10;15(10):2254. doi: 10.3390/nu15102254.
8
Global burden of female breast cancer and its association with socioeconomic development status, 1990-2044.全球女性乳腺癌负担及其与社会经济发展状况的关联,1990-2044 年。
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1827. doi: 10.1002/cnr2.1827. Epub 2023 Apr 24.
9
Obesity, Fat Distribution and Risk of Cancer in Women and Men: A Mendelian Randomisation Study.肥胖、脂肪分布与女性和男性癌症风险:一项孟德尔随机化研究。
Nutrients. 2022 Dec 9;14(24):5259. doi: 10.3390/nu14245259.
10
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy.肥胖与新辅助化疗后达到病理完全缓解的乳腺癌患者早期复发相关。
Sci Rep. 2022 Dec 7;12(1):21145. doi: 10.1038/s41598-022-25043-2.